These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18299847)

  • 21. The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.
    Claerhout I; Beele H; Verstraete A; Van den Broecke C; Kestelyn P
    Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):152-7. PubMed ID: 11372546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
    Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
    Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic cyclosporine in high-risk keratoplasty: long-term results.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 4)():422-8. PubMed ID: 7498559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
    Zhang W; Pan Z; Zhai C
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin C2hour monitoring after renal transplantation.
    Einecke G; Mai I; Fritsche L; Slowinski T; Waiser J; Glander P; Böhler T; Neumayer HH; Budde K
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):477-81. PubMed ID: 14703954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
    Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor].
    Reinhard T; Sundmacher R; Godehardt E; Heering P
    Ophthalmologe; 1997 Jul; 94(7):496-500. PubMed ID: 9333395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clear graft survival and immune reactions following emergency keratoplasty.
    Maier P; Böhringer D; Reinhard T
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):351-9. PubMed ID: 17024439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
    Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
    Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty.
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effectiveness and safety of topical 0.1% tacrolimus after high-risk penetrating keratoplasty].
    Li X; Zhang YN; Yin MY; Pan ZQ
    Zhonghua Yan Ke Za Zhi; 2019 Jun; 55(6):419-427. PubMed ID: 31189271
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of Immunosuppressants in High Rejection Risk Keratoplasty: A Meta-Analysis of Comparative Studies.
    Yu K; Lian XF; Jiang XY; Zhou SY
    Cornea; 2021 Jun; 40(6):800-807. PubMed ID: 33941717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical administration of tacrolimus and corticosteroids in tapering doses is effective in preventing immune rejection in high-risk keratoplasty: a 5-year follow-up study.
    Qi X; Wang L; Zhang X; Liu M; Gao H
    BMC Ophthalmol; 2022 Mar; 22(1):101. PubMed ID: 35246084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.
    Coupland SE; Krause L; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):116-24. PubMed ID: 8720682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty.
    Inoue K; Kimura C; Amano S; Sato T; Fujita N; Kagaya F; Kaji Y; Tsuru T; Araie M
    Jpn J Ophthalmol; 2001; 45(4):378-82. PubMed ID: 11485770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.